Toxoplasmosis–Schizophrenia Research
(last updated July 2011)
Welcome to the Toxoplasmosis–Schizophrenia
Research section. This site is maintained by the Stanley Medical Research
Institute (SMRI) and the Stanley
Division of Developmental Neurovirology for SMRI-funded researchers and others interested in
the possible etiological relationship between Toxoplasma gondii (and
related organisms) and schizophrenia (and related psychoses). The purpose of
the webpage is to make information on this line of research, including
background data and current research, easily available.
This
section will be updated periodically. Comments, suggestions, additions,
and corrections are welcomed. They can be sent to either E. Fuller Torrey, MD, or Robert H. Yolken, MD.
Related sites:
www.toxodb.org/toxo: provides detailed information on the genome of Toxoplasma gondii
http://www.schizophreniaforum.org/: a useful online forum to keep updated on schizophrenia research
TABLE OF CONTENTS
Introduction
I. All about Cats and T. gondii Transmission
II. Possible Transmission of T. gondii from Cats to Humans, Causing Schizophrenia
III. Epidemiological Similarities and Differences between Toxoplasmosis and Schizophrenia
IV. Effects of T. gondii on Behavior and Psychiatric Symptoms
V. Studies of T. gondii Antibodies in Schizophrenia
VI. Neurotransmitters and T. gondii
VII. Neuropathology of T. gondii
VIII. Treatment Approaches to Toxoplasmosis and Schizophrenia
Introduction
SMRI has undertaken
extensive research on infectious agents as one of the possible causes of
schizophrenia. Among the infectious agents that appear most promising is Toxoplasma
gondii, a protozoan parasite that causes toxoplasmosis and is carried by
cats and other felines. Until recently, toxoplasmosis was thought to be a
problem only for pregnant women who, if they became infected with T. gondii
during their pregnancy, risked having the organism cause damage to the growing
fetus. This is why pregnant women are advised to not change the litter in the
cat litter box. Infection with T. gondii
in other adults and children was thought to be either asymptomatic or to cause
an influenza-like or mononucleosis-like syndrome. It now seems possible that T.
gondii may be associated with schizophrenia and perhaps other psychiatric
syndromes.
Schizophrenia is a brain
disease that begins in young adults, typically between the ages of 16 and 30,
and is characterized by some combination of auditory hallucinations (hearing
voices), delusions, flattened affect, disordered thought patterns, bizarre
behavior, and social withdrawal. Schizophrenia affects approximately 1 percent
of the adult population and in most cases is a lifelong disease with remissions
and exacerbations. It is also a very expensive disease. Conservative estimates
place the cost of schizophrenia in the United States at more than $40 billion
a year.
For additional information on schizophrenia, see Torrey EF, Surviving Schizophrenia, 5th edition (New York, HarperCollins, 2006) and the following websites:
http://www.schizophrenia.com/
http://www.mentalhealth.com/
http://www.chovil.com/